UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000031853
Receipt No. R000035766
Scientific Title Investigator-initiated multi-institutional phase I clinical trial of NY-ESO-1-specific TCR gene-modified T cell therapy for adult T cell leukemia/lymphoma patients relapsed after allogeneic hematopoietic stem cell transplantation
Date of disclosure of the study information 2018/03/23
Last modified on 2021/10/08 09:56:49

No. Disposal Last modified on Item of update
1 Insert 2018/03/23 10:07:37
2 Update 2018/09/03 16:01:26 Institutions
3 Update 2018/09/20 17:43:01 Institutions
4 Update 2019/03/18 16:11:51 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address
Address

Last name of contact person

Last name of contact person
Zip code
Address
Address
Organization
Organization
Address
Address
Tel
Email
Institutions
5 Update 2019/03/18 16:14:16 Date of IRB
Anticipated trial start date
Last follow-up date
6 Update 2019/03/25 10:20:34 Address
Address
Address
Address
7 Update 2019/07/18 09:46:17 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
Target sample size
8 Update 2019/07/18 15:52:03 Address
Address
Address1
Organization
Organization
Address
Address
9 Update 2019/08/28 14:43:21 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
10 Update 2019/09/25 13:50:48 Interventions/Control_1
11 Update 2020/02/26 15:22:37 Last follow-up date
12 Update 2020/03/13 17:19:05 Institutions
13 Update 2020/06/26 17:33:50 Organization
Organization
Category of Funding Organization
14 Update 2020/06/26 17:35:22 Recruitment status
15 Update 2020/06/26 17:36:25 Number of participants that the trial has enrolled
16 Update 2021/02/26 10:34:22 Recruitment status
17 Update 2021/10/08 09:56:49 Last follow-up date


Contact us.